Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma (Q81872738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

title

Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

1

Neelapu SS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Munshi NC

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Jagannath S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Watson TM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Pennington R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Reynolds C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Barlogie B

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

Kwak LW

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

315-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968284 AND SRC:MED&resulttype=core&format=json

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Allogeneic hematopoietic cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Donor leukocyte infusions for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Myeloma proteins as tumor-specific transplantation antigens

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Antibody to a molecularly-defined antigen confined to a tumour cell surface

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Immunization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705057

7 January 2021